MYGN
Myriad Genetics·NASDAQ
--
--(--)
--
--(--)
MYGN fundamentals
Myriad Genetics (MYGN) Revenue Breakdown: Q3 2025 Business & Regional Performance
Myriad Genetics (MYGN) reported total revenue of 205.70M USD in Q3 2025, with its core business segment Testing contributing 100.00%. Regionally, United States remained the largest market, accounting for 93.19% of total revenue. Explore Myriad Genetics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Myriad Genetics (MYGN) reported total revenue of 205.70M USD in Q3 2025, with its core business segment Testing contributing 100.00%. Regionally, United States remained the largest market, accounting for 93.19% of total revenue. Explore Myriad Genetics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is Myriad Genetics's latest dividend and current dividend yield?Did Myriad Genetics beat or miss consensus estimates last quarter?What does Myriad Genetics do and what are its main business segments?What factors drove the changes in Myriad Genetics's revenue and profit?What guidance did Myriad Genetics's management provide for the next earnings period?What is Myriad Genetics's gross profit margin?What is the revenue and EPS growth rate for Myriad Genetics year over year?What were the key takeaways from Myriad Genetics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
